Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a potent class of drugs in the management of type 2 diabetes mellitus. These agents simulate the actions of naturally occurring GLP-1, stimulating https://tbookmark.com/story19745015/novel-glucagon-like-peptide-1-receptor-agonists-a-comprehensive-review